Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
Part of paid clinical trials in Hartford, Connecticut.
- Sponsor
- Matthew Grosso, MD
- Study ID
- NCT06479161
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Postoperative Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Accepted
Interventions
- Tranexamic acid — DRUG1.95 grams oral
Study Details
The primary purpose of this study is to evaluate postoperative pain. Secondary outcomes evaluated in this study will include range of motion (ROM), opioid consumption, and ambulation. Each outcome measure will be evaluated, oral tranexamic acid (TXA) in the experiment arm and placebo in the control arm, after total knee arthroplasty (TKA) at postoperative days 0-3, and weeks 1, 2, 6, and 12.
Key Dates
- Start date
- Jun 10, 2024
- Status verified
- Dec 2024
- Primary completion
- Feb 28, 2025
- Completion
- Mar 30, 2025
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: TXA\- 1.95 grams oral TXA (tranexamic acid) (3- 650 mg tablets) administered postop day one, postop day two and postop day three. Compounded by registered pharmacist and labeled with subject name and instructions for use.
- Placebo Comparator: Placebo\- 3 tablets administered postop day one, postop day two and postop day three. Compounded by registered pharmacist and labeled with subject name and instructions for use.
Primary Outcome Measure
Visual Analogue Scale (VAS) Pain scores [ Time Frame: postoperative day (POD) 0, 1, 2, 3 (+/- 0 days) and weeks 1 (+/- 0 days), 2 (+/- 2 days), 6 and 12 (+/- 7 days). ]
Central Contacts
- Gina Panek, BS860-714-4164
- Czarina Weinz860-714-0467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Trinity Health Of New England/CT Joint Replacement Institute | Hartford | Connecticut | 06105 | Matthew Grosso, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Hartford, CT
Related Studies
- Ketamine in Patients Undergoing TEVAR Procedures Receiving NCIPHASE2 · Recruiting · Sam Tyagi · Lexington, Kentucky
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce PainPHASE3 · Recruiting · University of California, San Francisco · San Francisco, California
- Use of a Vibration Tool for Postoperative Pain Control in Distal Radius FracturesNot Yet Recruiting · Northwestern University · Chicago, Illinois